Davis Jason
SEC insider (Form 3/4/5 filer). CIK 0001443533. Chief Financial Officer at FibroBiologics, Inc. (FBLG) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on May 4, 2026. Located in HOUSTON,, TX.
Companies Davis Jason has filed insider reports for
- FibroBiologics, Inc. (FBLG): Officer, Chief Financial Officer
- Virax Biolabs Group Ltd (VRAX): Officer, Chief Financial Officer
Davis Jason
CIK: 0001443533
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
